NCT05714501

Millipede AspiRation for Revascularization in Stroke (MARRS) Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 246 (actual)
• Sponsor: Perfuze · Industry
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

The objectives of the study are to examine the performance and safety characteristics of the Millipede System when used for revascularization of patients with acute ischemic stroke due to Large Vessel Occlusions (LVOs) and to record associated clinical outcomes.

Detailed description

Ischemic stroke is a life-threatening condition. Annually, approximately 795,000 people in the United States have a stroke. The MARRS study is an interventional, open label, single arm, multi center, prospective clinical investigation. The objectives of the study are to evaluate the performance and safety characteristics of the Millipede System in patients presenting with acute ischemic stroke due to LVOs and to record clinical outcomes.

Conditions

• Acute Ischemic Stroke

Interventions

Type	Name	Description
DEVICE	Millipede System	Mechanical thrombectomy

Timeline

• Start date: 2023-10-09
• Primary completion: 2025-03-08
• Completion: 2025-05-12
• First posted: 2023-02-06
• Last updated: 2026-03-11

Locations

23 sites across 3 countries: United States, France, Spain

Regulatory

• FDA-regulated device study